News
13hon MSNOpinion
FDA Commissioner Marty Makary’s pledge to reexamine the safety of medication abortion isn’t just pointless — it’s dangerous.
1dOpinion
MedPage Today on MSNHow Fast Is Too Fast for FDA Drug Review?In announcing his new Commissioner's National Priority Voucher (CNPV) program, FDA Commissioner Marty Makary, MD, MPH, ...
Qualifying manufacturers will be able to submit some data while clinical trials are ongoing. Marty Makary is the commissioner ...
Speaking at BIO2025, rare disease leaders from Ultragenyx, Amylyx and Yale questioned the need for the new regulatory pathway ...
U.S. health officials have expanded warnings about a rare heart side effect associated with the two leading COVID-19 vaccines ...
FDA Commissioner Marty Makary reportedly initiated a brief request last week to decline approval of a rare disease drug ...
But current and former agency staff, as well as medical ethics experts, say recent cuts at the FDA are already making it more ...
Mike Davis previously worked as clinical team leader at the FDA’s Division of Psychiatry before serving as chief medical officer for Usona Institute, a research organization advancing psychedelic ...
And more health news stories you need to start your week.
Curay, the FDA’s acting top drug regulator, is stepping down from her post after serving at the agency for more than eight ...
5hon MSN
Nestle announced it will eliminate artificial colors from its foods and beverages sold in the US by mid-2026.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results